中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
15期
77-79
,共3页
钼靶X线%彩超%BI-RADS分级%乳腺癌
鉬靶X線%綵超%BI-RADS分級%乳腺癌
목파X선%채초%BI-RADS분급%유선암
Digital X-ray mammography%Color doppler ultrasound%BI-RADS classification%Breast cancer
目的:通过对彩超与钼靶X线应用BI-RADS分级在乳腺癌诊断上的比较并分析其优缺点,以探讨结合二者应用于临床上诊断乳腺癌的价值。方法通过分析我院手术与病理结果证实的82例乳腺癌患者的钼靶X线和彩超影像表现及其BI-RADS分级,两者检查结果与病理检查结果对照。结果诊断率比较中彩超组(a)为87.80%,钼靶X线组(b)为75.60%,两者联合组(c)为95.24%,差异组间比较Pa:b=0.237,Pa:c=0.014,Pb:c=0.017;恶性诊断率彩超组为66.66%,钼靶X线组为73.33%,两者联合组为86.66%,差异组间比较Pa:b=0.164,Pa:c=0.003,Pb:c=0.001;BI-RADS等级比较中联合应用组2~3级与4级诊断率高于彩超组及钼靶X线组,差异有统计学意义(P<0.05)。结论两者联合应用可相互补充,对BI-RADS分级具有很高的灵敏度,将两者联合应用于临床可以提高乳腺癌患者的诊断率。
目的:通過對綵超與鉬靶X線應用BI-RADS分級在乳腺癌診斷上的比較併分析其優缺點,以探討結閤二者應用于臨床上診斷乳腺癌的價值。方法通過分析我院手術與病理結果證實的82例乳腺癌患者的鉬靶X線和綵超影像錶現及其BI-RADS分級,兩者檢查結果與病理檢查結果對照。結果診斷率比較中綵超組(a)為87.80%,鉬靶X線組(b)為75.60%,兩者聯閤組(c)為95.24%,差異組間比較Pa:b=0.237,Pa:c=0.014,Pb:c=0.017;噁性診斷率綵超組為66.66%,鉬靶X線組為73.33%,兩者聯閤組為86.66%,差異組間比較Pa:b=0.164,Pa:c=0.003,Pb:c=0.001;BI-RADS等級比較中聯閤應用組2~3級與4級診斷率高于綵超組及鉬靶X線組,差異有統計學意義(P<0.05)。結論兩者聯閤應用可相互補充,對BI-RADS分級具有很高的靈敏度,將兩者聯閤應用于臨床可以提高乳腺癌患者的診斷率。
목적:통과대채초여목파X선응용BI-RADS분급재유선암진단상적비교병분석기우결점,이탐토결합이자응용우림상상진단유선암적개치。방법통과분석아원수술여병리결과증실적82례유선암환자적목파X선화채초영상표현급기BI-RADS분급,량자검사결과여병리검사결과대조。결과진단솔비교중채초조(a)위87.80%,목파X선조(b)위75.60%,량자연합조(c)위95.24%,차이조간비교Pa:b=0.237,Pa:c=0.014,Pb:c=0.017;악성진단솔채초조위66.66%,목파X선조위73.33%,량자연합조위86.66%,차이조간비교Pa:b=0.164,Pa:c=0.003,Pb:c=0.001;BI-RADS등급비교중연합응용조2~3급여4급진단솔고우채초조급목파X선조,차이유통계학의의(P<0.05)。결론량자연합응용가상호보충,대BI-RADS분급구유흔고적령민도,장량자연합응용우림상가이제고유선암환자적진단솔。
Objective Application of BI-RADS grading to study the value of color doppler ultrasound and X-mammograpyon on the diagnosis of breast cancer. Methods 82 cases of breast cancer patients with color doppler ultrasound and X-mammograpyon data were selected. The test results of two methods werecompared with pathological findings. Results Compared with the pathological examination, the Ultrasound diagnosis rate was 87.80%, the X-ray mammography group(b) of 75.60%, combination of the two methods group(c) was 95.24%, the difference between groups Pa:b=0.237, Pa:c=0.014, Pb:c=0.017;the Ultrasound group malignant diagnosis rate was 66.66%, mammography X-ray group malignant diagnosis rate was 73.33%, both combined group malignant diagnosis rate was 86.66%, the difference between groups Pa:b=0.164, Pa:c=0.003, Pb:c=0.001, BI-RADS rating comparison application-level group combined 2-3 with four diagnostic ultrasound group and higher than X-ray mammography group, the difference was statistically significant P<0.05. Conclusion Combined with color doppler ultrasound and X-mammograpyon can improve the diagnostic rate of breast cancer patients.